Docs of the Month: US, China Most Prolific January Regulators

article image

The most medtech policy documents came out of US FDA and China’s National Medical Products Administration in January, according to Pathways’ Document Depot. A look at a few important releases last month from around the globe.

Docs of the Month is a regular column highlighting key findings from Pathway Document Depot, a running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.

US FDA and China’s National Medical Products Administration (NMPA) each rolled out nine new or updated policy documents last month, making them the most prolific among the global agencies and organizations tracked by Document Depot.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: